MGCD-265 (Glesatinib)

SKU: C-1216-5mg

Quantity (mg):

5 mg

Product Options

Quantity

$91.99

Catalog#: C-1216

Targets: c-Met

Synonym: MGCD-265; MGCD 265; MGCD265; Glesatinib

Chemical Name/IUPAC:N-((3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)carbamothioyl)-2-(4-fluorophenyl)acetamide

Technical Data

Product Name: MGCD-265 (Glesatinib)

Chemical Formula: C31H27F2N5O3S2

Molecular Weight: 619.7

CAS#: 936694-12-1

Appearance: Solid powder

Purity: > 99% by HPLC

Solubility: Soluble in DMSO

Storage: Room temperature for months, or -20ºC for 3 years

Description
MGCD-265 (Glesatinib) is an orally bioavailable, small-molecule, multitargeted tyrosine kinase inhibitor with potential antineoplastic activity. MGCD-265 binds to and inhibits the phosphorylation of several receptor tyrosine kinases (RTKs), including the c-Met receptor (hepatocyte growth factor receptor); the Tek/Tie-2 receptor; vascular endothelial growth factor receptor (VEGFR) types 1, 2, and 3; and the macrophage-stimulating 1 receptor (MST1R or RON).

MGCD-265 (Glesatinib)

Related products

BMS-906024

ABT-263 (Navitoclax)

MEK-162 (ARRY-162)

E-7090